Financial Instruments Risk - Liquidity Risk Narrative (Details) - CAD ($) $ in Thousands |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
[1] | Mar. 31, 2023 |
[1] | |||
| Disclosure of nature and extent of risks arising from financial instruments [line items] | ||||||||||
| Cash and cash equivalents | $ 137,921 | $ 132,625 | $ 107,569 | $ 138,210 | $ 136,095 | $ 255,592 | ||||
| Liquidity risk | ||||||||||
| Disclosure of nature and extent of risks arising from financial instruments [line items] | ||||||||||
| Cash and cash equivalents | 137,900 | |||||||||
| Shelf Prospectus, amount allowed, common shares | $ 250,000 | |||||||||
| Shelf Prospectus, effective period | 25 months | |||||||||
| Liquidity risk | Self-Insurance Policy | ||||||||||
| Disclosure of nature and extent of risks arising from financial instruments [line items] | ||||||||||
| Restricted cash | $ 43,900 | |||||||||
| ||||||||||